Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic colorectal cancer.
      Google Scholar   
Citation:
Oncogene
Year:
2021
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
No
DataSharing:
No
SDC:
No
Book Volume:
Parents:
None
Children:
None
Program:
TRP
Primary Committee:
Correl Sci NOS
Sec. Committees:
   
Pharmas:
Bristol-Myers Squibb, Genentech, Pfizer  
Grants:
U10CA180821, U10CA180882, UG1CA233163, P30CA 014089  
Corr. Author:
 
Authors:
                                                           
Networks:
ADM403, ALLIANCE, CA011, CA136, CA249, FL028, LAPS-MN026, LAPS-MO011, LAPS-NC007, LAPS-OH007, MN022, MUSC, NC042, WV025   
Study
CALGB-80405
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: